These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7988309)

  • 1. Complications of the pump pocket may represent a significant cause of incidents with implanted systems for intraperitoneal insulin delivery.
    Renard E; Bringer J; Jacques-Apostol D; Lauton D; Mestre C; Costalat G; Jaffiol C
    Diabetes Care; 1994 Sep; 17(9):1064-6. PubMed ID: 7988309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable insulin pumps: infections most likely due to seeding from skin flora determine severe outcomes of pump-pocket seromas.
    Renard E; Rostane T; Carriere C; Marchandin H; Jacques-Apostol D; Lauton D; Gibert-Boulet F; Bringer J
    Diabetes Metab; 2001 Feb; 27(1):62-5. PubMed ID: 11240448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catheter complications associated with implantable systems for peritoneal insulin delivery. An analysis of frequency, predisposing factors, and obstructing materials.
    Renard E; Baldet P; Picot MC; Jacques-Apostol D; Lauton D; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1995 Mar; 18(3):300-6. PubMed ID: 7555471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal delivery of insulin via mechanical pump: surgical implications.
    Udelsman R; Boyne MS; Loman KE; Saudek CD
    Langenbecks Arch Surg; 2000 Oct; 385(6):367-72. PubMed ID: 11127519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage activation in type 1 diabetic patients with catheter obstruction during peritoneal insulin delivery with an implantable pump.
    Kessler L; Tritschler S; Bohbot A; Sigrist S; Karsten V; Boivin S; Dufour P; Belcourt A; Pinget M
    Diabetes Care; 2001 Feb; 24(2):302-7. PubMed ID: 11213883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemophilus influenza infection of an implantable insulin-pump pocket.
    Levy RP; Borchelt MD; Kremer RM; Francis SJ; O'Connor CA
    Diabetes Care; 1992 Nov; 15(11):1449-50. PubMed ID: 1468268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Implantable insulin pump: surgical implantation under local anesthesia. (Technical note apropos of 35 cases)].
    Glock Y; Galinier P; Dalous P; Hanaire-Broutin H; Lacombe S; Lafon F; Tauber JP
    Ann Chir; 1992; 46(5):445-9. PubMed ID: 1416757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin underdelivery from implanted pumps using peritoneal route. Determinant role of insulin pump compatibility.
    Renard E; Bouteleau S; Jacques-Apostol D; Lauton D; Gibert-Boulet F; Costalat G; Bringer J; Jaffiol C
    Diabetes Care; 1996 Aug; 19(8):812-7. PubMed ID: 8842596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sudden death due to diabetic ketoacidosis following power failure of an insulin pump: Autopsy and pump data.
    Kjærulff MLBG; Astrup BS
    J Forensic Leg Med; 2019 Apr; 63():34-39. PubMed ID: 30856551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps.
    Catargi B; Breilh D; Gin H; Rigalleau V; Saux MC; Roger P; Tabarin A
    Diabetes Metab; 2001 Jun; 27(3):323-7. PubMed ID: 11431597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cutaneous complications in a diabetic patient treated by the insulin pump. Value of an 100 U/ml insulin preparation].
    Dupon M; Guillaume D; Ragnaud JM; Echinard E; Lacut JY
    Rev Med Interne; 1987; 8(5):513-5. PubMed ID: 3328250
    [No Abstract]   [Full Text] [Related]  

  • 13. Pump-pocket complications during long-term insulin delivery using an implanted programmable pump.
    Scavini M; Cristallo M; Sarmiento M; Dunn FL
    Diabetes Care; 1996 Apr; 19(4):384-5. PubMed ID: 8729167
    [No Abstract]   [Full Text] [Related]  

  • 14. Multicentre trial of a programmable implantable insulin pump in type I diabetes. The Point Study II Group.
    Int J Artif Organs; 1995 Jun; 18(6):322-5. PubMed ID: 8593967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The implantable insulin pump in the treatment of diabetes. Hopes and reality?].
    Vague P; Lassmann-Vague V; Belicar P; Alessis C
    Bull Acad Natl Med; 1996 Apr; 180(4):831-41; discussion 841-3. PubMed ID: 8925331
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Possibilities and risks of insulin pump therapy].
    Renner R; Lüddeke HJ
    Internist (Berl); 1990 Mar; 31(3):226-35. PubMed ID: 2187830
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute cutaneous complications and catheter needle colonization during insulin-pump treatment.
    Chantelau E; Lange G; Sonnenberg GE; Berger M
    Diabetes Care; 1987; 10(4):478-82. PubMed ID: 3622204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin pump-associated adverse events are common, but not associated with glycemic control, socio-economic status, or pump/infusion set type.
    Ross P; Gray AR; Milburn J; Kumarasamy IM; Wu F; Farrand S; Armishaw J; Wiltshire E; Rayns J; Tomlinson P; Wheeler BJ
    Acta Diabetol; 2016 Dec; 53(6):991-998. PubMed ID: 27585938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A preliminary trial of the programmable implantable medication system for insulin delivery.
    Saudek CD; Selam JL; Pitt HA; Waxman K; Rubio M; Jeandidier N; Turner D; Fischell RE; Charles MA
    N Engl J Med; 1989 Aug; 321(9):574-9. PubMed ID: 2761602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.